학술논문

Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)
Document Type
Article
Source
In: Arthritis and Rheumatology. (Arthritis and Rheumatology, May 2024, 76(5):763-776)
Subject
Language
English
ISSN
23265205
23265191